XOM vs. BMY
XOM (Exxon Mobil Corporation) and BMY (Bristol-Myers Squibb Company) are both stocks. XOM operates in Oil & Gas Integrated (Energy), while BMY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, XOM returned 9.64%/yr vs 1.00%/yr for BMY. At a 0.28 correlation, their price movements are largely independent.
Performance
XOM vs. BMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XOM achieves a 23.81% return, which is significantly higher than BMY's 8.27% return. Over the past 10 years, XOM has outperformed BMY with an annualized return of 9.64%, while BMY has yielded a comparatively lower 1.00% annualized return.
XOM
- 1D
- 0.28%
- 1M
- -2.35%
- YTD
- 23.81%
- 6M
- 25.40%
- 1Y
- 38.24%
- 3Y*
- 15.15%
- 5Y*
- 23.23%
- 10Y*
- 9.64%
BMY
- 1D
- 0.40%
- 1M
- 1.31%
- YTD
- 8.27%
- 6M
- 11.43%
- 1Y
- 18.34%
- 3Y*
- 0.45%
- 5Y*
- 0.73%
- 10Y*
- 1.00%
XOM vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XOM Exxon Mobil Corporation | 23.81% | 15.98% | 11.26% | -6.26% | 87.41% | 57.58% | -36.21% | 7.23% | -15.09% | -3.81% |
BMY Bristol-Myers Squibb Company | 8.27% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
Correlation
The correlation between XOM and BMY is -0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Jan 13, 1978 | 0.28 |
The correlation between XOM and BMY shifts across timeframes, from -0.10 (1 year) to 0.28 (all time), reflecting how their relationship changes across market environments.
Fundamentals
XOM:
$614.94B
BMY:
$116.75B
XOM:
$5.93
BMY:
$3.57
XOM:
24.80
BMY:
16.02
XOM:
1.15
BMY:
0.91
XOM:
1.93
BMY:
2.40
XOM:
2.42
BMY:
5.82
XOM:
$326.01B
BMY:
$48.48B
XOM:
$83.11B
BMY:
$33.33B
XOM:
$60.44B
BMY:
$13.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XOM vs. BMY — Risk / Return Rank
XOM
BMY
XOM vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Exxon Mobil Corporation (XOM) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XOM | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.89 | ||
| Sortino ratioReturn per unit of downside risk | +0.91 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.14 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 2.45 | 1.53 | +0.92 |
| Martin ratioReturn relative to average drawdown | 6.56 | 3.32 | +3.24 |
Loading charts...
Drawdowns
XOM vs. BMY - Drawdown Comparison
The maximum XOM drawdown since its inception was -62.40%, smaller than the maximum BMY drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for XOM and BMY.
Loading charts...
Drawdown Indicators
| XOM | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.40% | -72.03% | +9.63% |
Max Drawdown (1Y)Largest decline over 1 year | -15.69% | -12.05% | -3.64% |
Max Drawdown (3Y)Largest decline over 3 years | -18.92% | -36.85% | +17.93% |
Max Drawdown (5Y)Largest decline over 5 years | -20.51% | -47.67% | +27.16% |
Max Drawdown (10Y)Largest decline over 10 years | -61.34% | -47.67% | -13.67% |
Current DrawdownCurrent decline from peak | -13.68% | -17.79% | +4.11% |
Average DrawdownAverage peak-to-trough decline | -10.20% | -22.38% | +12.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.84% | 6.34% | -0.50% |
Volatility
XOM vs. BMY - Volatility Comparison
Exxon Mobil Corporation (XOM) has a higher volatility of 9.08% compared to Bristol-Myers Squibb Company (BMY) at 8.22%. This indicates that XOM's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XOM | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.08% | 8.22% | +0.86% |
Volatility (6M)Calculated over the trailing 6-month period | 20.51% | 18.18% | +2.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.51% | 27.08% | -2.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.77% | 24.02% | +2.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.20% | 25.29% | +2.91% |
Dividends
XOM vs. BMY - Dividend Comparison
XOM's dividend yield for the trailing twelve months is around 2.78%, less than BMY's 4.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.38% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
XOM Exxon Mobil Corporation | 2.78% | 3.32% | 3.57% | 3.68% | 3.22% | 5.70% | 8.44% | 4.92% | 4.74% | 3.66% | 3.30% | 3.69% |
Financials
XOM vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Exxon Mobil Corporation and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
XOM vs. BMY - Profitability Comparison
XOM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Exxon Mobil Corporation reported a gross profit of 31.36B and revenue of 83.16B. Therefore, the gross margin over that period was 37.7%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
XOM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Exxon Mobil Corporation reported an operating income of 5.29B and revenue of 83.16B, resulting in an operating margin of 6.4%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
XOM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Exxon Mobil Corporation reported a net income of 4.18B and revenue of 83.16B, resulting in a net margin of 5.0%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
Frequently Asked Questions
XOM and BMY have a correlation of -0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XOM has higher volatility (9.08%) compared to BMY (8.22%). In terms of maximum drawdown, XOM dropped -62.40% vs BMY's -72.03%.
XOM currently has the higher Sharpe Ratio (1.57 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XOM and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer